SCHEMBL1573772

SCHEMBL1573772

O=[N+]([O-])c1ccccc1NC1CC2COCC(C1)N2Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 6/20 0.61
MAPT P10636 4/20 0.47
RAB9A P51151 2/20 0.47
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 1/20 0.44
ROCK2 O75116 1/20 0.44
ARHGDIA P52565 1/20 0.44
ROCK1 Q13464 1/20 0.44
ALDH1A1 P00352 4/20 0.41
HTT P42858 1/20 0.41
LTA4H P09960 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
OPRK1 P41145 2/20 0.40
SIGMAR1 Q99720 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
KCNH2 Q12809 1/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1574218 0.91 MAPK1 (0.67) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL1573769 0.81 MAPK1 (0.48) MAPK1MAPTRAB9ANPSR1ALDH1A1
SCHEMBL1573767 0.81 MAPK1 (0.48) MAPK1MAPTRAB9ANPSR1ALDH1A1
SCHEMBL22716655 0.78 MAPK1 (0.53) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL31192586 0.78 MAPK1 (0.53) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL7240975 0.78 MAPK1 (0.54) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL7240972 0.78 MAPK1 (0.54) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL4014383 0.78 MEN1 (0.56) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL6159635 0.76 MAPK1 (1.00) MAPK1MAPTRAB9APKMNPSR1
SCHEMBL3604934 0.76 MAPK1 (0.52) MAPK1MAPTRAB9APKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed